TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
11.02
+0.07 (0.64%)
At close: Oct 31, 2025, 4:00 PM EDT
11.20
+0.18 (1.63%)
After-hours: Oct 31, 2025, 7:12 PM EDT
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $9.34 million as of October 31, 2025. Its market cap has decreased by -22.41% in one year.
Market Cap
9.34M
Enterprise Value
1.96M
1-Year Change
-22.41%
Ranking
Category
Stock Price
$11.02
Market Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $9.34M, a decrease of -80.49%. That is a compound annual growth rate of -31.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 9.95M | 323.88% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | 47.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.33B |
| Johnson & Johnson | 449.57B |
| AbbVie | 397.72B |
| UnitedHealth Group | 321.75B |
| AstraZeneca | 257.84B |
| Novartis AG | 237.42B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 216.57B |